HLB Co. Ltd (028300) - Net Assets

Latest as of March 2026: ₩493.87 Billion KRW ≈ $334.69 Million USD

Based on the latest financial reports, HLB Co. Ltd (028300) has net assets worth ₩493.87 Billion KRW (≈ $334.69 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩925.44 Billion ≈ $627.16 Million USD) and total liabilities (₩431.57 Billion ≈ $292.47 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how large is HLB Co. Ltd's balance sheet for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩493.87 Billion
% of Total Assets	53.37%
Annual Growth Rate	21.68%
5-Year Change	13.41%
10-Year Change	457.1%
Growth Volatility	76.73

HLB Co. Ltd - Net Assets Trend (2005–2025)

This chart illustrates how HLB Co. Ltd's net assets have evolved over time, based on quarterly financial data. Check HLB Co. Ltd (028300) tangible net worth to evaluate the tangible quality of the company's equity base.

Annual Net Assets for HLB Co. Ltd (2005–2025)

The table below shows the annual net assets of HLB Co. Ltd from 2005 to 2025. For live valuation and market cap data, see 028300 market cap.

Year	Net Assets	Change
2025-12-31	₩494.41 Billion ≈ $335.06 Million	-14.25%
2024-12-31	₩576.57 Billion ≈ $390.73 Million	-0.97%
2023-12-31	₩582.25 Billion ≈ $394.58 Million	-8.73%
2022-12-31	₩637.94 Billion ≈ $432.32 Million	+46.33%
2021-12-31	₩435.96 Billion ≈ $295.44 Million	-9.13%
2020-12-31	₩479.75 Billion ≈ $325.12 Million	+159.48%
2019-12-31	₩184.89 Billion ≈ $125.30 Million	+5.84%
2018-12-31	₩174.68 Billion ≈ $118.38 Million	+126.15%
2017-12-31	₩77.24 Billion ≈ $52.35 Million	-12.97%
2016-12-31	₩88.75 Billion ≈ $60.14 Million	+4.84%
2015-12-31	₩84.65 Billion ≈ $57.37 Million	+267.72%
2014-12-31	₩23.02 Billion ≈ $15.60 Million	+48.49%
2013-12-31	₩15.50 Billion ≈ $10.51 Million	-16.67%
2012-12-31	₩18.60 Billion ≈ $12.61 Million	-12.21%
2011-12-31	₩21.19 Billion ≈ $14.36 Million	-9.07%
2010-12-31	₩23.31 Billion ≈ $15.79 Million	-49.84%
2009-12-31	₩46.46 Billion ≈ $31.49 Million	+7.26%
2008-12-31	₩43.32 Billion ≈ $29.36 Million	+123.57%
2007-12-31	₩19.38 Billion ≈ $13.13 Million	-0.31%
2006-12-31	₩19.44 Billion ≈ $13.17 Million	+98.91%
2005-12-31	₩9.77 Billion ≈ $6.62 Million	--

Equity Component Analysis

This analysis shows how different components contribute to HLB Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 292507022000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	₩2.93 Billion	0.70%
Other Components	₩415.53 Billion	99.30%
Total Equity	₩418.46 Billion	100.00%

HLB Co. Ltd Competitors by Market Cap

The table below lists competitors of HLB Co. Ltd ranked by their market capitalization.

Company	Market Cap
Siriuspoint Ltd NYSE:SPNT	$2.76 Billion
ACC Limited NSE:ACC	$2.76 Billion
Shenzhen Gas Corp Ltd SHG:601139	$2.76 Billion
Uxi Unicomp Technology Co. Ltd. A SHG:688531	$2.76 Billion
Vapores SN:VAPORES	$2.75 Billion
Sumitomo Chemical India Limited NSE:SUMICHEM	$2.75 Billion
CarGurus NASDAQ:CARG	$2.75 Billion
Kangmei Pharmaceutical Co Ltd SHG:600518	$2.75 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in HLB Co. Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 576,572,200,390 to 418,457,232,960, a change of -158,114,967,430 (-27.4%).
Net loss of 220,500,871,610 reduced equity.
New share issuances of 2,029,300,000 increased equity.
Other factors increased equity by 60,356,604,180.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩-220.50 Billion	-52.69%
Share Issuances	₩2.03 Billion	+0.48%
Other Changes	₩60.36 Billion	+14.42%
Total Change	₩-	-27.42%

Book Value vs Market Value Analysis

This analysis compares HLB Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 9.72x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 27.78x to 9.72x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩1101.67	₩30600.00	x
2017-12-31	₩945.50	₩30600.00	x
2018-12-31	₩1980.23	₩30600.00	x
2019-12-31	₩1920.62	₩30600.00	x
2020-12-31	₩4539.18	₩30600.00	x
2021-12-31	₩4094.41	₩30600.00	x
2022-12-31	₩5222.63	₩30600.00	x
2023-12-31	₩4069.69	₩30600.00	x
2024-12-31	₩4396.90	₩30600.00	x
2025-12-31	₩3149.24	₩30600.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently HLB Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -52.69%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -261.96%
• Asset Turnover: 0.09x
• Equity Multiplier: 2.22x
Recent ROE (-52.69%) is below the historical average (-16.58%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	-12.22%	-7.88%	0.69x	2.26x	₩-5.33 Billion
2015	14.93%	32.86%	0.21x	2.19x	₩4.17 Billion
2016	-14.89%	-43.85%	0.16x	2.10x	₩-22.09 Billion
2017	-21.40%	-71.85%	0.12x	2.44x	₩-24.25 Billion
2018	14.51%	70.04%	0.12x	1.74x	₩7.87 Billion
2019	-24.01%	-115.53%	0.11x	1.96x	₩-62.88 Billion
2020	-16.69%	-142.57%	0.08x	1.47x	₩-128.07 Billion
2021	-22.51%	-140.53%	0.09x	1.71x	₩-141.72 Billion
2022	-12.25%	-43.49%	0.19x	1.52x	₩-141.95 Billion
2023	-35.80%	-437.17%	0.06x	1.43x	₩-239.94 Billion
2024	-15.95%	-135.02%	0.08x	1.54x	₩-149.64 Billion
2025	-52.69%	-261.96%	0.09x	2.22x	₩-262.35 Billion

Industry Comparison

This section compares HLB Co. Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $460,268,294,609
Average return on equity (ROE) among peers: -5.78%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
HLB Co. Ltd (028300)	₩493.87 Billion	-12.22%	0.87x	$2.76 Billion
ORIENTBIO Inc. (002630)	$65.49 Billion	6.21%	0.30x	$71.52 Million
Green Cross (005250)	$1.85 Trillion	1.30%	0.98x	$283.20 Million
Green Cross Holdings Preference Shares (005257)	$1.91 Trillion	2.89%	0.83x	$2.29 Million
Pharmicell (005690)	$101.58 Billion	-17.37%	0.34x	$411.92 Million
GeneOne Life Science Inc (011000)	$34.73 Billion	-18.69%	0.17x	$164.07 Million
Mgenplus Co. Ltd. (032790)	$46.48 Billion	-0.94%	0.63x	$16.13 Million
Daesung Microbiological Labs. Co. Ltd (036480)	$37.35 Billion	-1.82%	0.72x	$15.71 Million
Seoulin Bioscience Co.Ltd (038070)	$48.60 Billion	8.38%	0.37x	$24.62 Million
Hyundai Bioscience Co. Ltd (048410)	$45.27 Billion	-32.03%	0.17x	$384.00 Million

About HLB Co. Ltd

KQ:028300 Korea Biotechnology

Market Cap

$2.76 Billion

₩4.07 Trillion KRW

Market Cap Rank

#5087 Global

#110 in Korea

Share Price

₩30600.00

Change (1 day)

+2.17%

52-Week Range

₩25650.00 - ₩68200.00

All Time High

₩120800.00